Jubilant Pharmova Secures USFDA Approval For New Spokane Line 3

22 August 2026

Jubilant Pharmova Ltd.

USFDA approved commercial batch manufacturing for the first product on Spokane Line 3, enabling its planned late-FY27 commercialization and supporting Jubilant’s sterile-injectables CDMO expansion.